Krebs Biochemicals & Industries Limited (KREBSBIO.NS)
INR 73.54
(1.56%)
INR 73.54
(1.56%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 504.21 Million | 521.34 Million | 529.4 Million | 386.06 Million | 235.83 Million | 371.32 Million |
| Cost of Revenue | 612.96 Million | 256.77 Million | 737 Million | 522.32 Million | 329.1 Million | 388.99 Million |
| Gross Profit | -108.74 Million | 264.56 Million | -207.59 Million | -136.25 Million | -93.26 Million | -17.66 Million |
| Operating Expenses | 46.15 Million | 487.95 Million | 195.13 Million | 90.75 Million | 146.99 Million | 131.43 Million |
| Selling, General and Administrative Expenses | 46.15 Million | 8.59 Million | 11.19 Million | 32.86 Million | 9.38 Million | 11.96 Million |
| Research and Development Expenses | - | 11.25 Million | 16.38 Million | 14.65 Million | 9.69 Million | 9.54 Million |
| Other Expenses | - | 6.2 Million | 10.16 Million | 6.21 Million | 10.16 Million | 10.16 Million |
| Cost and Expenses | 659.11 Million | 744.73 Million | 932.13 Million | 613.07 Million | 476.1 Million | 520.43 Million |
| Operating Income | - | -217.18 Million | -402.91 Million | -227 Million | -240.26 Million | -149.1 Million |
| Interest Expense | 46.85 Million | 29.73 Million | 54.42 Million | 62.79 Million | 59.98 Million | 62.75 Million |
| Income Tax Expense | - | 65.35 Million | 13.87 Million | 6.21 Million | 12.72 Million | 10.72 Million |
| Earnings before Tax | -197.28 Million | -246.91 Million | -445.26 Million | -283.58 Million | -288.72 Million | -200.11 Million |
| Net Income | -197.28 Million | -246.91 Million | -445.26 Million | -283.58 Million | -288.72 Million | -200.11 Million |
| Earnings Per Share Basic | -9.15 | -11.45 | -20.65 | -14.45 | -16.04 | -12.03 |
| Earnings Per Share Diluted | -9.15 | -11.45 | -20.65 | -14.45 | -16.04 | -12.03 |
| Weighted Average Shares Outstanding | 21.56 Million | 21.56 Million | 21.56 Million | 19.62 Million | 18 Million | 16.63 Million |
| Weighted Average Shares Outstanding (Diluted) | 21.56 Million | 21.56 Million | 21.56 Million | 19.62 Million | 18 Million | 16.63 Million |
| Gross Margin | -0.22 | 0.51 | -0.39 | -0.35 | -0.40 | -0.05 |
| EBIT Margin | -0.16 | -0.29 | -0.62 | -0.44 | -0.77 | -0.25 |
| Profit Margin | -0.39 | -0.47 | -0.84 | -0.73 | -1.22 | -0.54 |
| EBITDA | -82.72 Million | -151.6 Million | -328.39 Million | -169.55 Million | -182.65 Million | -93.71 Million |
| Earnings Before Tax Margin | - | -0.42 | -0.76 | -0.59 | -1.02 | -0.40 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 128.88 Million | 504.21 Million | 119.72 Million | 129.77 Million | 148.9 Million | 105.81 Million |
| Cost of Revenue | 71.97 Million | 298.27 Million | 84.39 Million | 74.52 Million | 20.53 Million | 3.65 Million |
| Gross Profit | 56.91 Million | 205.93 Million | 35.33 Million | 55.24 Million | 128.36 Million | 102.16 Million |
| Operating Expenses | 95.78 Million | 360.84 Million | 83.19 Million | 93.45 Million | 154.47 Million | 144.89 Million |
| Selling, General and Administrative Expenses | 95.78 Million | - | 83.19 Million | 93.45 Million | 96.47 Million | 87.72 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 335 Thousand | 4.51 Million | 2.1 Million | 294 Thousand | 1.74 Million | 375 Thousand |
| Cost and Expenses | 167.75 Million | 659.11 Million | 167.58 Million | 167.97 Million | 175.01 Million | 148.54 Million |
| Operating Income | -38.86 Million | -154.9 Million | -47.85 Million | -38.2 Million | -24.37 Million | -42.35 Million |
| Interest Expense | 13.18 Million | 46.89 Million | 12.71 Million | 11.86 Million | 11.34 Million | 10.97 Million |
| Income Tax Expense | - | 67.49 Million | 16.67 Million | 17.34 Million | 16.98 Million | 16.49 Million |
| Earnings before Tax | -51.71 Million | -197.28 Million | -58.47 Million | -49.77 Million | -35.71 Million | -53.32 Million |
| Net Income | -51.71 Million | -197.28 Million | -58.47 Million | -49.77 Million | -35.71 Million | -53.32 Million |
| Earnings Per Share Basic | -2.40 | - | -2.72 | -2.31 | -1.66 | -2.47 |
| Earnings Per Share Diluted | -2.40 | - | -2.72 | -2.31 | -1.66 | -2.47 |
| Weighted Average Shares Outstanding | 21.56 Million | 21.53 Million | 21.49 Million | 21.56 Million | 21.56 Million | 21.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 21.56 Million | 21.53 Million | 21.49 Million | 21.56 Million | 21.56 Million | 21.56 Million |
| Gross Margin | 0.44 | 0.41 | 0.30 | 0.43 | 0.86 | 0.97 |
| EBIT Margin | -0.17 | - | -0.26 | -0.16 | -0.05 | -0.24 |
| Profit Margin | -0.40 | -0.39 | -0.49 | -0.38 | -0.24 | -0.50 |
| EBITDA | -21.96 Million | - | -31.13 Million | -20.9 Million | -7.26 Million | -25.82 Million |
| Earnings Before Tax Margin | -0.30 | -0.31 | -0.40 | -0.29 | -0.16 | -0.40 |
VRSRF
GREAVESCOT
603718
600282
603663
8150